Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

3 Tech Stocks Under $10 To Buy Now

Published 09/12/2016, 01:28 AM
Updated 07/09/2023, 06:31 AM

Here at Zacks, we don’t generally classify stocks as “cheap” or “expensive”, and rather than looking at the stock’s face value, we have a system that puts an emphasis on earnings estimate revisions to find stocks that will hopefully be winners for investors.

That being said, low-priced stocks can be attractive to smaller investors that can’t necessarily afford large stakes in companies with higher priced stocks. When looking at these low-priced stocks, we can look at the same trends in growth, value, and momentum and apply the Zacks Rank to properly analyze the potential that these companies have.

Today we’ve highlighted three stocks that fall under the broad “technology sector.” Each of these three stocks is currently trading for less than $10 per share and holds a Zacks Rank #1 (Strong Buy). Take a look at the strong estimate revision activity and other factors that make these companies stick out right now:

1. Daktronics Inc. (NASDAQ:DAKT)

Previous Close: $9.43

Daktronics is a leading manufacturer of electronic scoreboards, computer-programmable displays, and large screen video displays. The Zacks Consensus Estimate for the company’s current-quarter earnings has gained three cents over the past 30 days, and our consensus estimate for its quarterly revenue predicts sales growth of 43% this quarter. The stock also has an “A” grade for Momentum after shares gained more than 56% in the past 12 weeks.

2. Everyday Health, Inc. (NYSE:EVDY)

Previous Close: $7.25

Everyday Health is a provider of digital health and wellness solutions, including websites, mobile applications, YouTube shows, and social media destinations that are focused on weight loss, exercise, and nutrition. The stock’s current-quarter Zacks Consensus Estimate has gained nine cents in the past 30 days, and it currently has a positive Earnings ESP of 90% for the quarter.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Everyday Health has legitimized its business by growing its partnerships with professional brands by 40% in the first half of the year; this helped the company post 5% revenue growth in the previous quarter.

3. Oclaro Inc. (NASDAQ:OCLR)

Previous Close: $8.20

Oclaro is a leading provider of high performance optical components, modules, and subsystems for the telecommunications market. The Zacks Consensus Estimate for Oclaro’s current-quarter earnings has gained four cents over the last 60 days, and the company has surpassed the Zacks Consensus Estimate by an average of 101.25% in each of the trailing four quarters.

Our consensus estimates also call for Oclaro to see revenue growth of 31% and earnings growth of 373% this year; this has helped the stock earn an “A” grade for Growth in our Style Scores system.

Bottom Line

A stock’s market price is not a clear indicator of whether it is a good investment. However, the nice thing about the Zacks Rank is that it can be applied to stocks of any price. All of the stocks highlighted here hold a Zacks Rank #1 (Strong Buy) rankings, while also possessing other qualities that help them stick out. For smaller investors looking to find solid tech stocks at lower prices, this list is a great place to start.



EVERYDAY HEALTH (EVDY): Free Stock Analysis Report

DAKTRONICS INC (DAKT): Free Stock Analysis Report

OCLARO INC (OCLR): Free Stock Analysis Report

Original post
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.